Ashvattha Therapeutics
Redwood City
About Ashvattha Therapeutics
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $148.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2025)
- Website: avttx.com
- Phone: 650-868-5853
Industries & Categories
Biotechnology, Health Care, Neuroscience, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ashvattha-therapeutics-123825 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.